Nu-Med Plus, Inc. (NUMD)
USD 0.07
(-10.52%)
USD 0.07
(-10.52%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -118.25 Thousand USD | 31.12% |
| 2022 | -179.9 Thousand USD | 79.01% |
| 2021 | -818.06 Thousand USD | 58.48% |
| 2020 | -1.97 Million USD | -98.05% |
| 2019 | -994.96 Thousand USD | 13.82% |
| 2018 | -1.15 Million USD | -154.37% |
| 2017 | -453.97 Thousand USD | 62.72% |
| 2016 | -1.21 Million USD | -28.98% |
| 2015 | -939.32 Thousand USD | 17.14% |
| 2014 | -1.13 Million USD | -394.33% |
| 2013 | -230.44 Thousand USD | 10.12% |
| 2012 | -256.39 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -20.58 Thousand USD | 100.0% |
| 2024 Q2 | -16.03 Thousand USD | 0.0% |
| 2023 Q1 | -26.97 Thousand USD | -694.9% |
| 2023 FY | - USD | 29.79% |
| 2023 Q3 | -15.14 Thousand USD | 34.36% |
| 2023 Q2 | -23.07 Thousand USD | 14.45% |
| 2023 Q4 | -55.34 Thousand USD | -265.38% |
| 2022 Q1 | -57.55 Thousand USD | 45.53% |
| 2022 FY | - USD | 79.01% |
| 2022 Q4 | -3393.00 USD | 93.94% |
| 2022 Q3 | -55.96 Thousand USD | -2.17% |
| 2022 Q2 | -54.77 Thousand USD | 4.84% |
| 2021 Q3 | -113.72 Thousand USD | 54.07% |
| 2021 FY | - USD | 58.48% |
| 2021 Q2 | -247.58 Thousand USD | 29.49% |
| 2021 Q1 | -351.1 Thousand USD | 27.68% |
| 2021 Q4 | -105.66 Thousand USD | 7.09% |
| 2020 Q4 | -485.51 Thousand USD | -9.45% |
| 2020 Q2 | -898.17 Thousand USD | -527.04% |
| 2020 Q3 | -443.6 Thousand USD | 50.61% |
| 2020 FY | - USD | -98.05% |
| 2020 Q1 | -143.24 Thousand USD | 28.25% |
| 2019 Q1 | -416.92 Thousand USD | -25.54% |
| 2019 Q3 | -141.06 Thousand USD | 40.56% |
| 2019 FY | - USD | 13.82% |
| 2019 Q4 | -199.63 Thousand USD | -41.52% |
| 2019 Q2 | -237.33 Thousand USD | 43.07% |
| 2018 Q1 | -138.94 Thousand USD | 3.53% |
| 2018 Q4 | -332.09 Thousand USD | 35.95% |
| 2018 Q3 | -518.48 Thousand USD | -214.41% |
| 2018 Q2 | -164.91 Thousand USD | -18.69% |
| 2018 FY | - USD | -154.37% |
| 2017 Q2 | -107.71 Thousand USD | -58.55% |
| 2017 FY | - USD | 62.72% |
| 2017 Q3 | -134.16 Thousand USD | -24.55% |
| 2017 Q4 | -144.03 Thousand USD | -7.36% |
| 2017 Q1 | -67.93 Thousand USD | 76.02% |
| 2016 Q1 | -56.99 Thousand USD | 79.64% |
| 2016 FY | - USD | -28.98% |
| 2016 Q4 | -283.36 Thousand USD | 58.76% |
| 2016 Q3 | -687.15 Thousand USD | -305.88% |
| 2016 Q2 | -169.29 Thousand USD | -197.02% |
| 2015 FY | - USD | 17.14% |
| 2015 Q4 | -279.89 Thousand USD | 7.17% |
| 2015 Q3 | -301.51 Thousand USD | 22.19% |
| 2015 Q2 | -387.5 Thousand USD | -231.53% |
| 2015 Q1 | -116.88 Thousand USD | 77.87% |
| 2014 Q2 | -196.57 Thousand USD | -10.9% |
| 2014 FY | - USD | -394.33% |
| 2014 Q1 | -177.25 Thousand USD | -482.77% |
| 2014 Q4 | -528.11 Thousand USD | -122.65% |
| 2014 Q3 | -237.2 Thousand USD | -20.67% |
| 2013 Q3 | -87 Thousand USD | -161.99% |
| 2013 Q4 | -30.41 Thousand USD | 65.04% |
| 2013 FY | - USD | 10.12% |
| 2013 Q1 | -79.81 Thousand USD | 1.5% |
| 2013 Q2 | -33.2 Thousand USD | 58.39% |
| 2012 Q1 | -19.52 Thousand USD | 0.0% |
| 2012 Q2 | -45.84 Thousand USD | -134.78% |
| 2012 Q4 | -81.03 Thousand USD | 26.33% |
| 2012 Q3 | -109.99 Thousand USD | -139.94% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 56.885% |
| IR-Med Inc. | -4.89 Million USD | 97.583% |
| Polarean Imaging plc | -11.19 Million USD | 98.944% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 125.931% |
| Avitar, Inc. | -1.66 Million USD | 92.909% |
| AVITA Medical, Inc. | -39.56 Million USD | 99.701% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 89.84% |
| Össur hf. | 137.38 Million USD | 100.086% |
| Zecotek Photonics Inc. | -3.44 Million USD | 96.564% |
| QHSLab, Inc. | -91.29 Thousand USD | -29.538% |
| Wellstar International, Inc. | -1.35 Million USD | 91.282% |
| Össur hf. | 137.38 Million USD | 100.086% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 101.21% |
| Escalon Medical Corp. | -58.46 Thousand USD | -102.287% |
| Aurora Spine Corporation | -454.37 Thousand USD | 73.973% |
| BrainsWay Ltd. | -2.31 Million USD | 94.883% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 98.739% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 102.142% |
| Vivos Inc. | -2.79 Million USD | 95.766% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.966% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 40.18% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 92.912% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 68.789% |
| Nanomix Corporation | -8.13 Million USD | 98.547% |
| Theraclion SA | -2.05 Million USD | 94.233% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 83.274% |
| Positron Corporation | -1.45 Million USD | 91.856% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 93.132% |
| Lombard Medical, Inc. | -28.06 Million USD | 99.579% |
| ALR Technologies Inc. | -6.4 Million USD | 98.152% |
| Stratec SE | 39.91 Million USD | 100.296% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 217.154% |
| Heart Tronics, Inc. | -14.85 Million USD | 99.204% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 99.109% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 98.708% |
| VMS Rehab Systems, Inc. | -68.55 USD | -172414.953% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 96.217% |
| Ingen Technologies, Inc. | -8639.00 USD | -1268.897% |
| Odyssey Group International, Inc. | -2.13 Million USD | 94.469% |
| United American Healthcare Corporation | -59 Thousand USD | -100.439% |
| ECGI Holdings, Inc. | -2.99 Million USD | 96.045% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 81.204% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 76.994% |
| Urologix, Inc. | -6.34 Million USD | 98.136% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 90.458% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 84.561% |
| SS Innovations International, Inc. | -20.37 Million USD | 99.42% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 46.926% |
| Smith & Nephew plc | 1 Billion USD | 100.012% |
| NIOX Group Plc | 11.07 Million USD | 101.068% |
| Fuse Medical, Inc. | 1.83 Million USD | 106.444% |
| Broncus Holding Corporation | -25.19 Million USD | 99.531% |
| Brain Scientific Inc. | -7.93 Million USD | 98.509% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 98.741% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -542.712% |